OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astrocytic Regulation of Glutamate Transmission in Schizophrenia
Yu-Ying Mei, Dong Wu, Ning Zhou
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation
Ashley L. Comer, Micaël Carrier, Marie‐Ève Tremblay, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 168

Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System
Anna R. Malik, Thomas E. Willnow
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5671-5671
Open Access | Times Cited: 136

The Role of Cytokines in the Pathogenesis of Schizophrenia
Bartosz Dawidowski, Adrianna Górniak, Piotr Podwalski, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3849-3849
Open Access | Times Cited: 70

Astrocytes in schizophrenia
Tina Notter
Brain and Neuroscience Advances (2021) Vol. 5
Open Access | Times Cited: 60

Emerging evidence for astrocyte dysfunction in schizophrenia
Eva Cristina de Oliveira Figueiredo, Corrado Calì, Francesco Petrelli, et al.
Glia (2022) Vol. 70, Iss. 9, pp. 1585-1604
Open Access | Times Cited: 51

MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 33

Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101838-101838
Closed Access | Times Cited: 23

Alterations of Astrocytes in the Context of Schizophrenic Dementia
Vadim V. Tarasov, Andrey Svistunov, Vladimir N. Chubarev, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 65

Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
Andrea de Bartolomeis, Licia Vellucci, Mark C. Austin, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 909-909
Open Access | Times Cited: 29

An emerging role of astrocytes in aging/neuroinflammation and gut-brain axis with consequences on sleep and sleep disorders
Sergey V. Gudkov, Dmitriy E. Burmistrov, Elena Kondakova, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101775-101775
Closed Access | Times Cited: 29

Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia
Isabel Maurus, Alkomiet Hasan, Astrid Röh, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 5, pp. 499-515
Closed Access | Times Cited: 52

Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia
Luke A. Jelen, Sinéad King, Paul G. Mullins, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 5, pp. 497-508
Open Access | Times Cited: 50

Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
Caroline Madeira, Flávio Valdozende Alheira, Marilia Calcia, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 47

The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 32

Neuroinflammation and schizophrenia: The role of Toxoplasma gondii infection and astrocytic dysfunction
Alan W. Everett, Hany M. Elsheikha
Journal of Neuroimmunology (2025), pp. 578588-578588
Open Access

Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide
Lin Zhang, R.W.H. Verwer, Paul J. Lucassen, et al.
Journal of Psychiatric Research (2019) Vol. 121, pp. 31-38
Open Access | Times Cited: 39

Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis
Edward J. Goetzl, Vinod H. Srihari, Sinan Gülöksüz, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 30

A human iPSC-astroglia neurodevelopmental model reveals divergent transcriptomic patterns in schizophrenia
Attila Szabó, Ibrahim A. Akkouh, Matthieu Vandenberghe, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24

Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response
Ibrahim A. Akkouh, Hana Hříbková, Marta Grabiec, et al.
Schizophrenia Bulletin (2021) Vol. 48, Iss. 1, pp. 190-198
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top